{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:31:38Z","timestamp":1780385498819,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1245\/s10434-022-12791-8","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:02:27Z","timestamp":1670270547000},"page":"1823-1829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prophylactic Lymphaticovenous Anastomosis Performed with Lymphadenectomy is Oncologically Safe for Melanoma"],"prefix":"10.1245","volume":"30","author":[{"given":"Thomas Y.","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagri","family":"Cakmakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz J.","family":"Kwiecien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Gastman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"12791_CR1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-060116-022900","author":"JH Dayan","year":"2001","unstructured":"Dayan JH, Ly CL, Kataru RP, et al. Lymphedema: pathogenesis and novel therapies. Annu Rev Med. 2001. https:\/\/doi.org\/10.1146\/annurev-med-060116-022900.","journal-title":"Annu Rev Med."},{"key":"12791_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11050402","author":"T Penha","year":"2016","unstructured":"Penha T, Botter B, Heuts E, et al. Quality of life in patients with breast cancer\u2013related lymphedema and reconstructive breast surgery. J Reconstr Microsurg. 2016. https:\/\/doi.org\/10.3390\/jpm11050402.","journal-title":"J Reconstr Microsurg."},{"key":"12791_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25166","author":"RM Garza","year":"2018","unstructured":"Garza RM, Chang DW. Lymphovenous bypass for the treatment of lymphedema. J Surg Oncol. 2018. https:\/\/doi.org\/10.1002\/jso.25166.","journal-title":"J Surg Oncol."},{"key":"12791_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-006-3269-7","author":"S Matsubara","year":"2006","unstructured":"Matsubara S, Sakuda H, Nakaema M, et al. Long-term results of microscopic lymphatic vessel-isolated vein anastomosis for secondary lymphedema of the lower extremities. Surg Today. 2006. https:\/\/doi.org\/10.1007\/s00595-006-3269-7.","journal-title":"Surg Today."},{"key":"12791_CR5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0270-y","author":"F Boccardo","year":"2009","unstructured":"Boccardo F, Casabona F, De Cian F, et al. Lymphedema microsurgical preventive healing approach: A new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009. https:\/\/doi.org\/10.1245\/s10434-008-0270-y.","journal-title":"Ann Surg Oncol."},{"key":"12791_CR6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1624-4","author":"FM Boccardo","year":"2011","unstructured":"Boccardo FM, Casabona F, Friedman D, et al. Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol. 2011. https:\/\/doi.org\/10.1245\/s10434-011-1624-4.","journal-title":"Ann Surg Oncol."},{"key":"12791_CR7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4721-y","author":"S Feldman","year":"2015","unstructured":"Feldman S, Bansil H, Ascherman J, et al. Single institution experience with lymphatic microsurgical preventive healing approach (lympha) for the primary prevention of lymphedema. Ann Surg Oncol. 2015. https:\/\/doi.org\/10.1245\/s10434-015-4721-y.","journal-title":"Ann Surg Oncol."},{"key":"12791_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2017.08.029","author":"BNN Tran","year":"2018","unstructured":"Tran BNN, Angelo JP, Lee JH, et al. A novel pilot animal model for the surgical prevention of lymphedema: the power of optical imaging. J Surg Res. 2018. https:\/\/doi.org\/10.1016\/j.jss.2017.08.029.","journal-title":"J Surg Res."},{"key":"12791_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01188-3","author":"AM Menzies","year":"2001","unstructured":"Menzies AM, Amaria RN, Rozeman EA, et al. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC). Nat Med. 2001. https:\/\/doi.org\/10.1038\/s41591-020-01188-3.","journal-title":"Nat Med."},{"key":"12791_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709030","author":"J Weber","year":"2017","unstructured":"Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017. https:\/\/doi.org\/10.1056\/NEJMoa1709030.","journal-title":"N Engl J Med."},{"key":"12791_CR11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708539","author":"GV Long","year":"2017","unstructured":"Long GV, Hauschild A, Santinami M, et al. Adjuvant Dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017. https:\/\/doi.org\/10.1056\/NEJMoa1708539.","journal-title":"N Engl J Med."},{"key":"12791_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00065-6","author":"AMM Eggermont","year":"2021","unstructured":"Eggermont AMM, Blank CU, Mandal\u00e0 M, et al. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG\/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Lancet Oncol. 2021. https:\/\/doi.org\/10.1016\/S1470-2045(21)00065-6.","journal-title":"Lancet Oncol."},{"key":"12791_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01121-y","author":"P Bhave","year":"2021","unstructured":"Bhave P, Pallan L, Long GV, et al. Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis. Br J Cancer. 2021. https:\/\/doi.org\/10.1038\/s41416-020-01121-y.","journal-title":"Br J Cancer."},{"key":"12791_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.04.471","author":"CN Owen","year":"2020","unstructured":"Owen CN, Shoushtari AN, Chauhan D, et al. Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy. Ann Oncol. 2020. https:\/\/doi.org\/10.1016\/j.annonc.2020.04.471.","journal-title":"Ann Oncol."},{"key":"12791_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30099-3","author":"V Franke","year":"2019","unstructured":"Franke V, van Akkooi ACJ. The extent of surgery for stage III melanoma: how much is appropriate? Lancet Oncol. 2019. https:\/\/doi.org\/10.1016\/S1470-2045(19)30099-3.","journal-title":"Lancet Oncol."},{"key":"12791_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12544","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017. https:\/\/doi.org\/10.1111\/dth.12544.","journal-title":"N Engl J Med."},{"key":"12791_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3182a4d626","author":"DW Chang","year":"2013","unstructured":"Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg. 2013. https:\/\/doi.org\/10.1097\/PRS.0b013e3182a4d626.","journal-title":"Plast Reconstr Surg."},{"key":"12791_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-018-9897-7","author":"JW Granzow","year":"2018","unstructured":"Granzow JW. Lymphedema surgery: the current state of the art. Clin Exp Metastas. 2018. https:\/\/doi.org\/10.1007\/s10585-018-9897-7.","journal-title":"Clin Exp Metastas."},{"key":"12791_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/micr.30246","author":"MF Scaglioni","year":"2017","unstructured":"Scaglioni MF, Fontein DBY, Arvanitakis M, et al. Systematic review of lymphovenous anastomosis (LVA) for the treatment of lymphedema. Microsurgery. 2017. https:\/\/doi.org\/10.1002\/micr.30246.","journal-title":"Microsurgery."},{"key":"12791_CR20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1635117","author":"AK Greene","year":"2018","unstructured":"Greene AK, Goss JA. Diagnosis and staging of lymphedema. Semin Plast Surg. 2018. https:\/\/doi.org\/10.1055\/s-0038-1635117.","journal-title":"Semin Plast Surg."},{"key":"12791_CR21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3401829","author":"C Cakmakoglu","year":"2020","unstructured":"Cakmakoglu C, Kwiecien GJ, Schwarz GS, et al. Lymphaticovenous bypass for immediate lymphatic reconstruction in locoregional advanced melanoma patients. J Reconstr Microsurg. 2020. https:\/\/doi.org\/10.1055\/s-0039-3401829.","journal-title":"J Reconstr Microsurg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12791-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T21:44:17Z","timestamp":1675892657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12791-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["12791"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12791-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"1 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have nothing to disclose. No funding was received for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}